Normal tissue tolerance to external beam radiation therapy: Skin;Dose de tolérance des tissus sains: la peau et les phanères

Cancer/Radiotherapie

Volumn 14, Issue 4-5, 2010, Pages 379-385

  Ginot, A ^a   Doyen, J ^a   Hannoun Levi J M ^a   Courdi, A ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

Hair; Ionizing radiation; Nail; Radiotherapy; Skin; Toxicity

Indexed keywords

ACUTE TOXICITY; ALOPECIA; AUTOIMMUNE DISEASE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHRONIC TOXICITY; DNA REPAIR; EXTERNAL BEAM RADIOTHERAPY; HUMAN; IONIZING RADIATION; MALNUTRITION; NAIL DISEASE; OBESITY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RISK BENEFIT ANALYSIS; SENESCENCE; SHORT SURVEY; SKIN DISEASE; SKIN TOXICITY; SMOKING; TREATMENT DURATION;

FEMALE; HUMANS; MALNUTRITION; OBESITY; RADIATION TOLERANCE; RADIATION, IONIZING; RADIODERMATITIS; RADIOTHERAPY; SKIN; SKIN DISEASES; SKIN NEOPLASMS; SKIN ULCER; SMOKING;

EID: 77955332429     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2010.03.015     Document Type: Short Survey

References (54)

1. Archambeau J.O., Pezner R., Wasserman T. Pathophysiology of irradiated skin and breast. Int J Radiat Oncol Biol Phys 1995, 31:1171-1185.
2. Azria D., Magné N., Zouhair A., Castadot P., Culine S., Ychou M., et al. Radiation recall: a well recognized but neglected phenomenon. Cancer Treat Rev 2005, 31:555-570.
3. Azria D., Ozsahin M., Kramar A., Peters S., Atencio D.P., Crompton N.E., et al. Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy. Clin Cancer Res 2008, 14:6284-6288.
4. Bartelink H., Roelofsen F., Eschwège F., Rougier P., Bosset J.F., Gonzalez D.G., et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997, 15:2040-2049.
5. Bentzen S.M., Agrawal R.K., Aird E.G., Barrett J.M., Barrett-Lee P.J., Bliss J.M., et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 2008, 9:331-341.
6. Beriwal S., Heron D.E., Kim H., King G., Shogan J., Bahri S., et al. Intensity-modulated radiotherapy for the treatment of vulvar carcinoma: a comparative dosimetric study with early clinical outcome. Int J Radiat Oncol Biol Phys 2006, 64:1395-1400.
7. Bernier J., Bonner J., Vermorken J.B., Bensadoun R.J., Dummer R., Giralt J., et al. Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. Ann Oncol 2008, 19:142-149.
8. Budach V., Stuschke M., Budach W., Baumann M., Geismar D., Grabenbauer G., et al. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial. J Clin Oncol 2005, 23:1125-1135.
9. Calais G., Alfonsi M., Bardet E., Sire C., Germain T., Bergerot P., et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999, 91:2081-2086.
10. Coleman C.N., Turrisi A.T. Radiation and chemotherapy sensitizers and protectors. Crit Rev Oncol Hematol 1990, 10:225-252.
11. Denham J.W., Hauer-Jensen M. The radiotherapeutic injury--a complex 'wound'. Radiother Oncol 2002, 63:129-145.
12. Denis F., Garaud P., Bardet E., Alfonsi M., Sire C., Germain T., et al. Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems. Int J Radiat Oncol Biol Phys 2003, 55:93-98.
13. Denis F., Garaud P., Bardet E., Alfonsi M., Sire C., Germain T., et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 2004, 22:69-76.
14. Dorr W., Hendry J.H. Consequential late effects in normal tissues. Radiother Oncol 2001, 61:223-231.
15. Dutreix J. Human skin: early and late reactions in relation to dose and its time distribution. Br J Radiol Suppl 1986, 19:22-28.
16. Goldschmidt H., Sherwin W.K. Reactions to ionizing radiation. J Am Acad Dermatol 1980, 3:551-579.
17. Gottlober P., Krahn G., Peter R.U. Cutaneous radiation syndrome: clinical features, diagnosis and therapy. Hautarzt 2000, 51:567-574.
18. Gruber B.L., Marchese M.J., Kew R.R. Transforming growth factor-beta 1 mediates mast cell chemotaxis. J Immunol 1994, 152:5860-5867.
19. Harper J.L., Franklin L.E., Jenrette J.M., Aguero E.G. Skin toxicity during breast irradiation: pathophysiology and management. South Med J 2004, 97:989-993.
20. Hopewell J.W. The skin: its structure and response to ionizing radiation. Int J Radiat Biol 1990, 57:751-773.
21. Hopewell J.W. The volume effect in radiotherapy--its biological significance. Br J Radiol 1997, 70(Spec No):S32-S40.
22. Hymes S.R., Strom E.A., Fife C. Radiation dermatitis: clinical presentation, pathophysiology, and treatment. J Am Acad Dermatol 2006, 54:28-46.
23. Koeberle D., Burkhard R., von Moos R., Winterhalder R., Hess V., Heitzmann F., et al. Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer. Br J Cancer 2008, 98:1204-1209.
24. Kupper T.S. The activated keratinocyte: a model for inducible cytokine production by non-bone marrow-derived cells in cutaneous inflammatory and immune responses. J Invest Dermatol 1990, 94:146S-150S.
25. Lawenda B.D., Gagne H.M., Gierga D.P., Niemierko A., Wong W.M., Tarbell N.J., et al. Permanent alopecia after cranial irradiation: dose-response relationship. Int J Radiat Oncol Biol Phys 2004, 60:879-887.
26. Maalej M., Frikha H., Kochbati L., Bouaouina N., Sellami D., Benna F., et al. Radio-induced malignancies of the scalp about 98 patients with 150 lesions and literature review. Cancer Radiother 2004, 8:81-87.
27. Maciejewski B., Withers H.R., Taylor J.M., Hliniak A. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx. Part 2. Normal tissue responses: acute and late effects. Int J Radiat Oncol Biol Phys 1990, 18:101-111.
28. Malkinson F.D., Keane J.T. Radiobiology of the skin: review of some effects on epidermis and hair. J Invest Dermatol 1981, 77:133-138.
29. Martin M., Lefaix J., Delanian S. TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target?. Int J Radiat Oncol Biol Phys 2000, 47:277-290.
30. Matanoski G.M., Seltser R., Sartwell P.E., Diamond E.L., Elliott E.A. The current mortality rates of radiologists and other physician specialists: specific causes of death. Am J Epidemiol 1975, 101:199-210.
31. Matzinger O., Duclos F., van den Bergh A., Carrie C., Villa S., Kitsios P., et al. Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991. Eur J Cancer 2009, 45:2825-2834.
32. Mendelsohn F.A., Divino C.M., Reis E.D., Kerstein M.D. Wound care after radiation therapy. Adv Skin Wound Care 2002, 15:216-224.
33. Monroe A.T., Feigenberg S.J., Mendenhall N.P. Angiosarcoma after breast-conserving therapy. Cancer 2003, 97:1832-1840.
34. Okumura S., Mitsumori M., Kokubo M., Yamauchi C., Kawamura S., Oya N., et al. Late skin and subcutaneous soft tissue changes after 10gy boost for breast conserving therapy. Breast Cancer 2003, 10:129-133.
35. Ortholan C., Estivalet S., Barillot I., Costa A., Gérard J.P. Guide des procédures de radiothérapie externe 2007. Cancer Radiother 2007, 11:329-330.
36. Perkins J.L., Liu Y., Mitby P.A., Neglia J.P., Hammond S., Stovall M., et al. Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study. J Clin Oncol 2005, 23:3733-3741.
37. Pigott K.H., Dische S., Vojnovic B., Saunders M.I. Sweat gland function as a measure of radiation change. Radiother Oncol 2000, 54:79-85.
38. Pommier P., Gomez F., Sunyach M.P., D'Hombres A., Carrie C., Montbarbon X. Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol 2004, 22:1447-1453.
39. Poortmans P.M., Collette L., Bartelink H., Struikmans H., Van den Bogaert W.F., Fourquet A., et al. The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial. Cancer Radiother 2008, 12:565-570.
40. Rao J., Dekoven J.G., Beatty J.D., Jones G. Cutaneous angiosarcoma as a delayed complication of radiation therapy for carcinoma of the breast. J Am Acad Dermatol 2003, 49:532-538.
41. Richards G.M., Tome W.A., Robins H.I., Stewart J.A., Welsh J.S., Mahler P.A., et al. Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region. Breast Cancer Res Treat 2009, 114:307-313.
42. Roy I., Fortin A., Larochelle M. The impact of skin washing with water and soap during breast irradiation: a randomized study. Radiother Oncol 2001, 58:333-339.
43. Rubin P., Constine L.S., Fajardo L.F., Phillips T.L., Wasserman T.H., Bartelink H., et al. Late effects consensus conference: RTOG/EORTC. Radiother Oncol 1995, 35:5-7.
44. Schaffer M., Thoma M., Wilkowski R., Schaffer P., Duhmke E. Radio-chemotherapy as a preoperative treatment for advanced rectal cancer. Evaluation of downstaging and morbidity. Onkologie 2002, 25:352-356.
45. Schmuth M., Sztankay A., Weinlich G., Linder D.M., Wimmer M.A., Fritsch P.O., et al. Permeability barrier function of skin exposed to ionizing radiation. Arch Dermatol 2001, 137:1019-1023.
46. Spencer S.A., Harris J., Wheeler R.H., Machtay M., Schultz C., Spanos W., et al. RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys 2001, 51:1299-1304.
47. Steinert M., Weiss M., Gottlober P., Belyi D., Gergel O., Bebeshko V., et al. Delayed effects of accidental cutaneous radiation exposure: fifteen years of follow-up after the Chernobyl accident. J Am Acad Dermatol 2003, 49:417-423.
48. Sulman E.P., Schwartz D.L., Le T.T., Ang K.K., Morrison W.H., Rosenthal D.I., et al. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes. Int J Radiat Oncol Biol Phys 2009, 73:399-409.
49. Tanvetyanon T., Padhya T., McCaffrey J., Zhu W., Boulware D., Deconti R., et al. Prognostic factors for survival after salvage reirradiation of head and neck cancer. J Clin Oncol 2009, 27:1983-1991.
50. Thames H.D., Bentzen S.M., Turesson I., Overgaard M., Van den Bogaert W. Time-dose factors in radiotherapy: a review of the human data. Radiother Oncol 1990, 19:219-235.
51. Turesson I. The progression rate of late radiation effects in normal tissue and its impact on dose-response relationships. Radiother Oncol 1989, 15:217-226.
52. Turesson I., Nyman J., Holmberg E., Oden A. Prognostic factors for acute and late skin reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys 1996, 36:1065-1075.
53. Von Joyet G, Hohl K. Die biologische hautreaktion in der tiefentherapie als funktion der feldgröße: ein gesetz der strahlentherapie. Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 1955;82:387-400.
54. Whelan T.J., Pignol J.P., Levine M.N., Julian J.A., Mackenzie R., Parpia S., et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010, 362:513-520.